About
Nanomedicine Delivery
Areas of Focus
Categories
NanotechDrug Delivery & FormulationBiotech
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
159
By Phase
PHASE1/PHASE2: 1PHASE2: 2PHASE1: 1
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1COMPLETED: 1TERMINATED: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05395624Lead Sponsor
Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
PHASE1/PHASE2Recruiting
65 participants
Started: Feb 2, 2023 · Completed: May 1, 2026
NCT05387837Lead Sponsor
Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME
PHASE2Active, not recruiting
50 participants
Started: Aug 31, 2022 · Completed: Sep 30, 2025
NCT05105607Lead Sponsor
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of D-4517.2 After Subcutaneous Administration in Healthy Participants
PHASE1Completed
16 participants
Started: Jan 11, 2022 · Completed: Aug 31, 2022
NCT04458298Lead Sponsor
A Study to Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients
PHASE2Terminated
28 participants
Started: Aug 11, 2020 · Completed: Aug 12, 2022
Funding History (1)
D
Jul 21, 2025
Locations (1)
Headquarters
Redwood City, CA, United States
Map
Loading map...